MedTrace Logo

Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens

NCT00625313 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 617

Last updated 2015-08-19

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) when implanted in the posterior chamber of the human eye for the optical correction of aphakia following cataract extraction.

Conditions

  • Aphakia

Interventions

DEVICE

HMY Model YA-60BB IOL

Following phacoemulsification cataract extraction, insertion of a Hoya HMY posterior chamber intraocular lens will be performed.

Sponsors & Collaborators

  • Hoya Surgical Optics, Inc.

    lead INDUSTRY

Principal Investigators

  • Steven L. Ziemba, M. Sc · Hoya Surgical Optics / Fullerton Regulatory & Clinical

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00625313 on ClinicalTrials.gov